An AI agent designed a RISC-V CPU core in about 12 hours. Now an AI agent is writing and testing its firmware on real silicon.

SAN FRANCISCO, July 14, 2026 — Embedder, the AI coding agent for firmware and embedded systems, and Verkor, the company behind the autonomous chip design system Conductor, today announced a partnership linking AI-driven silicon design to AI-driven firmware development. Together, the two companies cover the full stack — from a written spec to verified embedded software.

New silicon has always waited on software. Every chip needs bring-up code, drivers, and reference firmware before anyone can build on it — work that normally leans on vendor ecosystems built up over years. VerCore — the RISC-V core Conductor just designed — has none of that. Embedder builds that context from scratch, grounding it in the reference documentation. Then it drives the test equipment to prove the firmware actually works on real silicon.

“Chip design used to take months. Verkor just cut it down to a day,” said Ethan Gibbs, CEO of Embedder. “That makes firmware the next bottleneck, and firmware is the problem we built Embedder to solve. A brand-new core nobody has ever written code for is normally the hardest week of a firmware engineer’s career. For Embedder it’s a normal Tuesday.”

Verkor’s Conductor produced VerCore, a complete RISC-V CPU core, from a 219-word prompt in roughly 12 hours. In simulation the core runs at 1.48 GHz and posts a CoreMark score of 3,261. An FPGA implementation of Vercore is fully operational.

“A system is only proven when software runs successfully on its hardware. AI-based software and hardware co-development speeds up building and validating a fully working system, taking it from years to days. This partnership gives AI-designed silicon a software story on day one and pushes fully integrated system development and deployment to the next level for the industry,” said Suresh Krishna, CEO of Verkor.

About Embedder. Embedder is the AI coding agent for firmware and embedded systems. It understands the reference documentation and drives test equipment, closing the loop between source and silicon so embedded teams can get to market faster. Engineering teams across automotive, defense, IoT, and consumer electronics are using Embedder to generate verified firmware for complex applications.

About Verkor. Verkor, founded by top AI researchers and semiconductor veterans, builds semiconductors end-to-end — from concept to verified, tape-out-ready layout (GDSII) — through its platform, Conductor. Proven on numerous ASIC and FPGA designs, Conductor compresses time-to-tape-out from years to days. Leading-edge customers are using Conductor to build chips for the data center, networking, automotive, and IoT, among other areas.

Media Contacts
Jonah Perry — [email protected]
David Chin — [email protected]

SOURCE Embedder; Verkor

Series A round with strategic investment from Tether and participation from Blockchange Ventures and Lasagna will make PACT the infrastructure layer for USA₮ across payroll, earned wage access, credit, and payments.

SAN FRANCISCO, July 14, 2026 — Pact Labs today announced its Series A financing, anchored by a strategic investment from Tether, the world’s largest company in the digital asset ecosystem, with participation from Blockchange Ventures and Lasagna. The $7 million round will accelerate the buildout of infrastructure, bringing USA₮, a U.S. dollar-backed stablecoin issued by Anchorage Digital Bank, N.A., which Tether has collaborated to launch, to payroll, earned wage access, credit, and payments for millions of American workers.

America’s $10 trillion payroll system still runs on rails built decades ago. Workers wait weeks for money they’ve already earned — and paid over $12 billion in overdraft fees last year waiting. PACT’s infrastructure tokenizes the paycheck, making wages instant, credit programmable, and payments 24/7.

“With Tether as our strategic partner, USA₮ becomes the digital dollar working Americans actually use — every payday.”

“USA₮ was built to serve real people, and nothing is more real than a paycheck,” said Bo Hines, CEO of Tether USA₮. “Pact Labs gives us the rails to put digital dollars designed to be compliant with U.S. regulations directly into the hands of millions of American workers — faster, cheaper, and without the intermediaries that slow them down.”

Through its SDKs, Pact Labs has already deployed hundreds of thousands of embedded wallets and live stablecoin payroll flows across enterprise platforms, with additional partnership announcements to follow.

About Pact Labs
Pact Labs is the development and infrastructure-building arm of PACT, responsible for designing and deploying the technical systems that power the PACT protocol and its consumer products. Pact Labs builds the core wallet, data, and payment infrastructure, and smart contract architecture that connect the PACT Protocol to real-world fintechs and their end users. Its integrations have facilitated over $1.9 billion in credit across emerging markets and now powers compliant on-chain payroll infrastructure in partnership with Payactiv and Tether‘s USAT. Pact Labs operates as a key member of the PACT Consortium, providing the technical foundation that the Consortium’s global network of fintechs, asset managers, and infrastructure partners depend on. Follow Pact Labs online: X | Web

About PACT Foundation
PACT is the orchestration layer for global stablecoin finance, providing a protocol that connects fintech platforms, stablecoin issuers, and institutional capital onto a single programmable settlement layer. The PACT protocol provides permissioned smart contracts built on a permissionless settlement layer, enabling fintech platforms to plug directly into stablecoin rails without rebuilding existing backends. Core capabilities include 24/7 on-chain settlement replacing legacy ACH infrastructure, autonomous stablecoin liquidity routing for payroll, lending, and EWA, and automated reconciliation that eliminates intermediaries and distributes value in real time. PACT is the infrastructure layer powering compliant, global stablecoin finance at scale. Follow PACT online: X | Telegram | Discord | Medium | Web

About USA₮
USA₮ is a dollar-backed stablecoin issued by Anchorage Digital Bank that Tether, the global leader in stablecoin technology, has collaborated to launch. Purpose-built to serve the U.S. market and support American regulatory standards, USA₮ is a foundational rail for the next generation of American commerce, trade, and finance.

USA₮ underscores Tether‘s commitment to driving U.S. dominance and leadership in the evolving digital asset economy. As part of the broader Tether ecosystem, USA₮ aims to set a new benchmark in the U.S. for utility-driven stablecoins designed to deliver long-term value, strong governance, and real-world applications.

Media Contact:
Brady Nagel
Head of Marketing, Pact Labs
[email protected]

SOURCE Pact Labs

Martinson Will Lead Atombeam’s Aggressive Growth Plans for Neurpac, its AI-powered Software Solution Designed to Address the Infrastructure Challenges of the AI Era

MORAGA, Calif., July 14, 2026 — Atombeam, an AI technology company that enables organizations to exponentially increase the available bandwidth of their existing infrastructure with software alone, today announced the appointment of veteran executive leader Cody Martinson as president of the company’s growing Neurpac division. Martinson will oversee all operations of the division, which includes engineering, product marketing and sales.

“Cody has a proven track record of bringing true innovation to emerging technology markets,” said Charles Yeomans, founder and CEO of Atombeam. “The demand for real-time data transmission across constrained networks — among them satellite links, cellular connections, and legacy industrial infrastructure — is accelerating faster than traditional solutions can keep up. Cody understands this problem deeply, and he understands why Neurpac is uniquely positioned to solve it.”

Powered by AI that encodes and decodes patterns within data in milliseconds, Neurpac enables compaction that makes all data far smaller, searchable, inherently secure, always accessible and lightweight for real-time exchanges. Neurpac decreases the size of data by 75% and enables any connection to process exponentially more of it, with available bandwidth on any wired or wireless network – including cellular and satellite –  increasing by a factor of 4x or more.

Neurpac can be deployed in any environment or existing stack with no new hardware in mere minutes, and works with any kind of data, including block, file, video, and SCADA. Neurpac is proven in use with financial services companies, the U.S. military and in other high-demand environments where enterprises require mission-critical data to move unimpeded in any direction even on bandwidth-constrained environments. Neurpac also enables data centers to achieve exceptional efficiency gains and is ideally suited for large-scale database transfers.

“Neurpac reflects the innovation of people like James Luciani, senior vice president of engineering at Atombeam. Previously, Jim helped found and led engineering for Akamai’s Emerging Mobile Business Unit, where he architected products that dramatically improved Quality of Experience (QoE) for mobile customers and powered in-vehicle content delivery, from firmware updates to entertainment systems. Before that, he led next-generation switching and routing product development at Ericsson, taking their internally developed family of routing products from concept through deployment,” said Martinson. “Technological milestones often require a corresponding infrastructure transformation, but what we are seeing today is unprecedented because of the sheer computing power AI requires, and its impact on existing networks, systems, and data centers. With Neurpac, businesses have an alternative to the monumental capital expenditures required to build out their infrastructure for AI and other burgeoning data and bandwidth-heavy workloads.”

Martinson brings nearly two decades of senior leadership experience to Atombeam’s Neurpac division. Before joining Atombeam he was the president, director at Telleqt, a global AI software company that specializes in enabling businesses to use predictive models to derive more value from their data. Prior to that, Martinson served as president of Artacle after serving as the CEO of DANATEQ, the provider of a self-learning cognitive analytics platform. He received his bachelor’s from Northwood University.

About Atombeam

Atombeam is an AI technology company that uses AI to overcome the infrastructure challenges exacerbated by the stateless nature of Large Language Models (LLMs) and the dramatic growth of connected machines. The company’s Neurpac solution enables organizations to shrink the size of all data, including file, block, SCADA and video by 75%. Neurpac also increases available bandwidth by up to 9x, strengthens security, and radically decreases latency with a software-only solution that can be deployed in existing stacks in just minutes. Enterprises gain the ability to do more with, and extend the life of, legacy infrastructure while simultaneously improving the performance of state-of-the-art wired, cellular and satellite networks. Atombeam is also developing the Persistent Cognitive Machine (PCM), a new AI architecture that supports continuous learning with real memory, delivering the understanding required for in-the-moment decision making in a solution light enough for chips and devices. For more information, visit www.atombeamtech.com or follow us on LinkedIn, Facebook or YouTube.

Media Contact:
Ken Phillips
Guyer Group for Atombeam
P: 781-996-1866
E: [email protected]

SOURCE Atombeam

DAYTON, Ohio, July 14, 2026 — AmeriWater, a leading provider of water purification solutions for critical healthcare applications, has completed the acquisition of Med Water Systems (“Med Water” or the “Company”). The addition of Med Water will significantly expand AmeriWater’s presence in the clinical laboratory and sterile processing markets, deepening its ability to serve hospitals, healthcare systems, and diagnostics facilities across the United States.

Med Water Systems is a provider of high-purity water systems for clinical analyzers and sterile processing applications, serving customers across the U.S. Founded in 2014 and headquartered in Woods Cross, Utah, Med Water has established itself as a valuable partner to major health systems by providing highly reliable water systems combined with an industry-leading national service model.

“We are excited to welcome Med Water to AmeriWater. Together, we are creating a leading clinical water platform with expanded technical expertise, service capabilities, and resources to support customers who depend on reliable, high-quality water systems every day,” said Doug Lohse, CEO of AmeriWater. “Med Water has earned a strong reputation for customer focus and technical excellence, and we look forward to building on that foundation as we continue to serve the critical needs of our customers.”

“We are excited to join AmeriWater and believe this partnership represents an important next step for Med Water Systems, our employees, and our customers,” said Richard Day, CEO at Med Water. “Together, we will have the scale, capabilities, and resources to pursue new growth opportunities while continuing to deliver the responsiveness and expertise that our customers have come to expect.”

BofA Securities acted as the exclusive financial advisor to Med Water.

About AmeriWater
AmeriWater is an industry leader in the design, manufacture, installation, and supply of water purification systems and services for the healthcare sector, including dialysis and sterile processing, as well as industrial and other applications. AmeriWater offers a broad portfolio of configurable products and components that meet stringent regulatory and customer standards. AmeriWater is headquartered in Dayton, Ohio. For more information, visit www.ameriwater.com.

About Med Water Systems
Med Water Systems is a manufacturer of laboratory water purification systems for clinical analyzers, offering the highest-purity water in high volumes for research labs, healthcare facilities, and hospitals. The Company’s product portfolio includes laboratory systems, sterile processing devices, and a recurring consumables and service offering. Med Water Systems is headquartered in Woods Cross, Utah. For more information, visit www.medwatersystems.com.

About Edgewater Capital Partners
Headquartered in Cleveland, Ohio, Edgewater Capital Partners is a sector-focused private equity firm investing in middle-market performance materials and services businesses. The firm has extensive experience investing in people, technology, and infrastructure to accelerate the growth trajectory of specialty industrials, advanced materials, specialty chemicals, and life sciences businesses. Over twenty-five years of industry-specific investing has allowed the firm to develop a deep understanding of the complexities and nuances common to these businesses. For more information, please visit www.edgewatercapital.com.

SOURCE AmeriWater

Transit brings predictable locked rate stablecoin conversion to platforms managing stablecoin balances
across major stablecoins, including USDC, USDG, and PYUSD

NEW YORK, July 14, 2026 — Paxos Labs, the enterprise-grade stablecoin infrastructure provider, today announced the launch of Amplify Transit (“Transit”), stablecoin conversion technology that enables platforms, protocols, and treasuries to move between major stablecoins across chains at predictable fees and locked rates. By providing the infrastructure for stablecoin conversion and movement, Transit allows platforms to maintain control over their customer relationships, interfaces, and margins. Already live and operating at scale, Transit has moved almost $30 million (as of July 13) on Robinhood Chain since going live on July 1, 2026.

Through a single API integration, Transit enables platforms to convert between USDC, USDG, and PYUSD with guaranteed output amounts and around-the-clock availability. Transit is chain-agnostic by design and initially supports movement across Ethereum and Robinhood Chain. Additionally, Amplify Transit has been selected as the integration of choice for Morpho, Jumper, Across, and Arcus as they build on Robinhood Chain.

“Stablecoin adoption has reached a point where issuance is only the beginning,” said Bhau Kotecha, Co-Founder at Paxos Labs. “As platforms manage more stablecoins across more chains, they need infrastructure that allows them to move those assets predictably and efficiently. We built Transit to give platforms predictable economics at any scale while allowing them to maintain control over the experience and value they provide to their customers.”

As platforms begin supporting multiple stablecoins and operating across multiple chains, moving between those assets becomes increasingly complex and fragmented. A payments company may settle in PYUSD, a trading desk may hold USDC, and an exchange may operate on USDG, yet all of these assets must be converted, moved and unified before platforms can effectively put them to use.

Transit gives platforms a predictable way to manage this movement at scale. Exchanges, wallets, treasuries, fintechs, and protocols managing stablecoin balances receive a fixed fee per route, regardless of the size of the transaction, while rates are locked at the time of submission to guarantee the output amount before settlement. Conversions are available around the clock, including nights, weekends, and holidays, matching the always-on nature of the markets it serves.

“Robinhood Chain shows that stablecoins are becoming central to new financial ecosystems, and the volume Transit has already powered demonstrates the need for infrastructure that can move assets predictably from day one. Transit gives platforms the flexibility to support that growth while maintaining control over their economics and customer experience,” added Kotecha.

Transit adds to Paxos Labs’ product suite, acting as the movement layer of Amplify, the company’s infrastructure stack for platforms that want to mint, move and monetize digital assets. Amplify platforms can launch branded stablecoins, move between stablecoins and chains through Transit, and put stablecoin balances to work through Amplify Earn, all through a single integration.

ABOUT PAXOS LABS
Paxos Labs is the enterprise-grade stablecoin monetization infrastructure provider that gives platforms the tools to mint, move, and monetize digital assets, making them productive for their users. Its flagship product, the Amplify Suite, is a single integration to mint branded stablecoins, orchestrate stablecoin movement across chains, and embed yield. Incubated within Paxos and built on its $180B+ track record in tokenization and more than a decade of regulatory expertise, Paxos Labs brings institutional trust and rigor to the integration layer that makes stablecoins composable and accessible for the platforms building on them.

For more information visit paxoslabs.com

Media Contact
[email protected]

SOURCE Paxos Labs

NEW YORK, July 14, 2026 — Job Research Foundation, which seeks to help find a cure and treatments for Job Syndrome, has announced the ninth round of grant funding. The Foundation will award up to two grants in the amount of $200,000 each over a two-year period for scientific research into the causes of, and treatments for, Job Syndrome. To date, the organization has funded a total of seventeen research projects across the world.

Grant applications can be found online at https://www.jobresearchfoundation.org/grant-proposal-application. The deadline to apply is October 16, 2026.

The long-term goal of the Foundation is to help advance research to find a cure for Job Syndrome, a rare multisystem immunodeficiency disorder. In the short term, the Foundation hopes the research will improve the treatments for current patients. Previous applicants are encouraged to re-apply as well as collaborate with other institutions to expand their research. The application process is open to researchers worldwide and awardees will be announced in January 2027.

Also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), Job Syndrome was discovered in 1966 and is a rare multisystem immunodeficiency disorder found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional details.

MEDIA CONTACT: Risa B. Hoag, GMGPR, 845-627-3000, [email protected]

SOURCE Job Research Foundation

IRVINE, Calif., July 14, 2026 — TiaLinx, Inc., a leader in advanced sensing, autonomous surveillance, and space‑domain intelligence technologies, today announced that Maj. Gen. Clinton E. Crosier, USAF/USSF (Ret.), has joined the company’s Advisory Board. Maj. Gen. Crosier brings more than three decades of senior leadership experience across national security space operations, Space Domain Awareness (SDA), strategic force development, and advanced cloud technology applications.  

Maj. Gen. Crosier’s distinguished career includes serving as the Director of Space Force Planning and the principal architect of the creation of the United States Space Force. He previously served as Deputy Director of Operations at U.S. Strategic Command, where he oversaw the operational acceptance and early employment of the Geosynchronous Space Situational Awareness Program (GSSAP). As Director of Requirements for the U.S. Air Force (HAF/A5R), he led the development and approval of the original requirements for the SILENT BARKER program—two of the most consequential SDA capabilities fielded in the last decade.

 “We are honored to welcome Maj. Gen. Crosier to the TiaLinx Advisory Board,” said Dr. Fred Mohamadi, Founder and CEO of TiaLinx. “His operational insight, strategic vision, and deep understanding of SDA architectures will be invaluable as we advance our next‑generation sensing and autonomous intelligence platforms. His experience transitioning space‑based surveillance systems from concept to operational reality aligns directly with TiaLinx’s mission.”

Maj. Gen. Crosier is also the Founder and CEO of DeltaV Strategies and was the inaugural leader of the $1B Aerospace & Satellite business at Amazon Web Services, where he helped accelerate cloud adoption across the global space and geospatial industries for thousands of customers on six Continents.   

“I am excited to join TiaLinx at this pivotal moment,” said Maj. Gen. Crosier. “The company’s innovative approach to wide‑field sensing, autonomous processing, and scalable space‑domain intelligence has the potential to meaningfully enhance national security space operations. I look forward to supporting the team as they continue to push the boundaries of what is possible.”

Maj. Gen. Crosier’s appointment strengthens TiaLinx’s strategic advisory capabilities as the company expands its portfolio of advanced radar, electro‑optical, and AI‑driven surveillance technologies for government and commercial customers.

 TiaLinx develops advanced AI-assisted sensing, autonomous surveillance, and space‑domain intelligence systems that enable persistent awareness across air, ground, and orbital environments. With a strong intellectual‑property foundation and a history of innovation, TiaLinx delivers mission‑critical technologies for national security and commercial applications.

Media Contact:
Fred Mohamadi
949-285-6255
[email protected]

SOURCE TiaLinx, Inc.

Strategic investment will speed the rollout of Hexivon’s technology designed to eliminate PFAS in water for good

DALLAS, July 14, 2026 — Strategic investment will speed the rollout of Hexivon’s technology designed to eliminate PFAS in water for good

Hexivon, a Dallas-based water technology company, today announced a new investment from Hillwood, a Perot company. Hexivon eliminates polyfluoroalkyl substances (PFAS), also known as “forever chemicals,” from water rather than just filtering them out. The investment expands Hillwood’s infrastructure portfolio into advanced water technologies as utilities, industry and government agencies seek long-term solutions to the PFAS problem.

“We invested in Hexivon because we believe the company has developed a disruptive approach to addressing one of the most pressing environmental challenges facing communities today. We believe this collaboration can help accelerate adoption of meaningful PFAS treatment solutions across the country.”

— Ross Perot, Jr., Chairman of Hillwood

The only proven system that pulls PFAS from flowing water and destroys it for good

Most methods move PFAS around. Carbon filters, ion exchange, and reverse osmosis pull PFAS out of water, but leave waste that must be hauled off and stored. Hexivon works differently. It works at any ambient temperature and destroys PFAS at the molecular level on site. It breaks the chemicals apart and leaves nothing harmful behind.

In a 2025 pilot in Cary, North Carolina, drinking water tested at 40 parts per trillion of PFAS. After Hexivon treatment, the level was non-detectable. The system cleaned 150,000 gallons per day and made zero waste. Independent, EPA-certified labs checked the results.

Collaboration built to bring the technology to market and meet growing demand

“Hillwood brings far more than capital to this relationship. Their experience developing complex infrastructure projects, working with public-sector stakeholders and deploying long-term investment capital makes them an ideal strategic partner as we accelerate commercialisation of our PFAS destruction technology.”

— Kevin Boscamp, Chairman of Hexivon

Demand for PFAS treatment is growing fast. It is driven by new federal regulations and increased investment in water projects. In Texas, House Bill 500 (HB500) sent more than $1 billion to the Texas Water Development Board for water projects, including PFAS cleanup. Across Dallas-Fort Worth, 29 public water systems have exceeded EPA standards for PFAS, underscoring the need for treatment solutions and funding.

Together, Hillwood and Hexivon plan to accelerate deployment of PFAS destruction systems. The goal is simple: cleaner water for municipal, industrial and government customers across the United States.

Funding is available for Dallas-Fort Worth Water Systems

Texas HB500 funding can help pay for PFAS treatment in your community, and Hexivon is ready to help your system apply. The deadline is July 30, so time is short. Hexivon connects qualifying DFW water systems with engineering partners to guide the HB500 application, at no charge.

Contact Hexivon to connect with an engineering partner:
[email protected]
949-503-9341

About Hexivon
Hexivon is a Dallas-based water technology company focused on the treatment and destruction of PFAS and other emerging contaminants. Through its proprietary treatment platform, the company serves municipal utilities, industrial facilities, government agencies and environmental remediation projects across the United States. Learn more at hexivon.com.

About Hillwood
Hillwood, a Perot company, is one of the nation’s leading real estate development and investment firms with expertise spanning industrial, commercial, residential and public-sector infrastructure projects. Since 1988, Hillwood has developed and invested in transformative projects throughout North America, creating long-term value through strategic development, infrastructure investment and capital deployment.

Media Contact:
Braden Reddall
510-604-7535

SOURCE Hexivon

Hospital investors lead oversubscribed financing

DURHAM, N.C., July 14, 2026 — 410 Medical, Inc., a medical device company focused on innovative technologies for emergency and critical care, today announced the completion of a $12 million financing round. Orlando Health Ventures led the round, with participation from Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General, and a new undisclosed strategic investor.

The new funding will be used to scale 410 Medical’s commercial operations and support the launch of LifeFlow’s next-generation infuser.

“The heightened interest in this round reflects the confidence investors and customers have in 410 Medical’s mission and products,” said Kyle Chenet, Chief Executive Officer at 410 Medical. “With this funding, we’re able to expand our commercial reach, bringing LifeFlow to more clinicians and investing in the next generation of our technology. We’re grateful to Orlando Health Ventures for leading this round and excited to welcome Tampa General and an additional strategic partner to our syndicate.”

Backing Continued Commercial Growth

410 Medical’s LifeFlow products are used by more than 500 hospitals and EMS agencies across the country to help clinicians deliver fluid and blood quickly and effectively for patients experiencing sepsis, hemorrhagic shock, and other life-threatening conditions. Nearly 80,000 patients have been treated using LifeFlow. This financing enables the company to accelerate LifeFlow adoption and reach into new hospital systems and EMS agencies nationwide.

“Orlando Health Ventures is proud to lead this round and deepen our partnership with 410 Medical,” said Bobby Helmedag, Managing Director of Orlando Health Ventures. “LifeFlow addresses a critical gap in resuscitative care, and we’ve seen firsthand the impact it can have for clinicians and patients. We’re excited to support the team as they scale commercial operations and advance the next generation of the LifeFlow infuser.”

Investing in the Next Generation of LifeFlow

Alongside its commercial expansion, 410 Medical is investing in the future expansion of LifeFlow technologies. The next-generation device, planned for launch in 2027, builds on feedback from nearly ten years of experience partnering with front-line medical providers working tirelessly to provide effective resuscitation for critically ill patients. Speed, portability and ease of use are essential in these moments. The new LifeFlow technology will address these and other unmet needs. 

About 410 Medical, Inc.

Founded in 2013, 410 Medical is a North Carolina-based medical device company focused on advanced resuscitation technologies to improve the care of critically ill patients. Our lead product LifeFlow^® received FDA clearance in 2016 and is used to enhance the administration of fluid and blood products for patients with sepsis, hemorrhagic shock, and other life-threatening conditions. 410 Medical is committed to providing innovative technologies, education, and support for emergency and critical care providers to deliver effective resuscitation when minutes matter.

For more information visit www.410medical.com

Media Contact:
Carla Hoffman
[email protected]

SOURCE 410 Medical, Inc.